Antibody-drug conjugates (ADCs) represent a groundbreaking class of therapeutics that combine the specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small-molecule drugs. This synergistic approach allows for
Semaglutide is a synthetic analog of the human glucagon-like peptide-1 (GLP-1), developed to manage type 2 diabetes effectively. This therapeutic agent demonstrates the potential to enhance glycemic control, promote weight loss,
Polyethylene glycol (PEG) derivatives have become pivotal in the pharmaceutical industry, revolutionizing drug delivery systems and enhancing the efficacy of various therapeutic agents. The unique properties of PEG derivatives, including
